The typical private investment process comes with a negotiation between the company and the possible investor. It can be challenging to determine a product or company value, especially when it comes to high-risk product development. For example, the development of drug therapies or medical technology products require a large amount of funding and comes with a high risk. Although there are various valuation methods available, Catalyze focuses on the risk-adjusted net present value method (rNPV method), which is seen as “the golden standard” in life sciences.
A must-have if you’re interested in getting your business to the next level